You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Colorcon
Merck
Medtronic
Moodys

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Patent: 7,974,927

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,974,927
Title:Mailing machine and initialization method
Abstract: The mailing machine and a method of initializing it are based on an unremovable program memory, which contains an initialization program. A removable authorization device is operationally connected to the mailing machine and is designed such that it can be interrogated. The interrogation is performed before and during the initialization of the mailing machine with predetermined INIT data. A security module connected to the program memory serves for checking the authorization and can prevent initialization without authorization. The initialization of the mailing machine takes place at the goods receiving location in the destination country by switching into an initialization mode, authorization of the initialization by means of the authorization device, input of initialization data and ending of the initialization and cancellation of the authorization.
Inventor(s): Reisinger; Katrin (Oranienburg, DE)
Assignee: Francotyp-Postalia GmbH (Birkenwerder, GB)
Application Number:09/917,541
Patent Claims:see list of patent claims

Details for Patent 7,974,927

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial Francotyp-Postalia GmbH (Birkenwerder, GB) 2020-07-27 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
McKinsey
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.